by Annie De Groot | Aug 20, 2020 | Events, News
With the 2020 TIDES USA Virtual conference right around the corner, we at EpiVax are proud to sponsor this event, as we have year after year. Our CEO and leader in #FearlessScience Dr. Anne De Groot will be presenting a talk on a generic case study New Dogs/Old...
by Annie De Groot | Jun 28, 2019 | Events
TIDES Europe: Oligonucleotide and Peptide Therapeutics Tuesday, November 12th – Friday, November 15th RAI Amsterdam Convention Centre Amsterdam, Netherlands Right before our annual Immunogenicity and Tolerance seminar in Amsterdam, you will find us partnering at...
by Annie De Groot | Jun 28, 2019 | Events
UPDATE: Review Dr. Anne De Groots presentation here Therapeutic Peptides and Oligonucleotides: Regulations, Standards and Quality USP Workshop Monday, November 4th – Tuesday, November 5th The U.S. Pharmacopoeia (USP) Therapeutic Peptides and Oligonucleotides:...
by Adam | Oct 5, 2018 | News
This original article was published on October 2nd, 2018 in ConvergenceRI. PROVIDENCE, RI – The U.S. Food and Drug Administration announced on Tuesday, Oct. 2, that the federal agency has awarded EpiVax and CUBRC a $1 million contract over two years to establish best...
